Afuco™ Anti-Human GKN1 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-GKN1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies binding protein specific for the GKN1 polypeptide are used for treatment of type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy.
Supplier Creative Biolabs
Product # AFC-301CL
Pricing Inquiry
Host Humanized
Target GKN1
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4 °C, -20°C if preferred
Feedback